We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Data released by Hungary's state statistics bureau indicate that
the country's production of pharmaceuticals and raw materials was 8.1 percent
higher than in 2003.
According to industry data supplied by Japanese market research sources,
US drug major Pfizer has secured third place in the country's prescription drug
market.
Senior company sources at the US arm of Indian generics maker Ranbaxy
have confirmed that a lawsuit has been filed by US drug major Pfizer relating
to its version of antihypertensive agent Accupril (quinapril).
Russian government officials have claimed that prescriptions for
patients entitled to free drugs under the country's new reimbursement framework
have risen by between six and 10 times this year.
Following intense speculation, Swiss drug maker Novartis AG has announced
that it is to acquire Germany's second-largest generics producer, Hexal AG,
as well as a 67.7% stake in US generics maker Eon Labs.